Melodiol Global Health Ltd. (COPHF)

[jedijazz]

Combined Company is expected to have a cash balance of approximately $48
million, providing considerable financial flexibility to progress its growth strategy. $COPHF

[BlazingStocks]

Yes, up almost 8% on just about 60% of its 10-day average volume.

[budfoxfun]

Closing green!

COPHF

[BlazingStocks]

I'm excited to see how the $COPHF Animal and Human CBD products sell in America. I am more excited about the Animal CBD products...it's relatively new.

[BlazingStocks]

Thanks for sharing that link on $COPHF!

[jedijazz]

Once merged, The Highbrid Lab is able to immediately commence selling its
Animal and Human CBD products within the USA which is expected to add
considerable revenue. $COPHF

[ProfitScout]

$COPHF News on the Redlight Holland Merger from June 16th with full details:

Creso Pharma and Red Light Holland Merge to Introduce The HighBrid Lab (TM), a Leading Global Psychedelics x Cannabis Company, Specializing in Recreational Products, Applied Science, Technology and Innovation
Click here:
https://stockhouse.com/news/press-releases/2021/06/16/creso-pharma-and-red-light-holland-merge-to-introduce-the-highbrid-lab-tm-a

About Creso Pharma (COPHF)

Creso Pharma brings pharmaceutical expertise and methodological rigor to the cannabis world and strives for the highest quality in its products. The company develops cannabis and hemp derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. Creso Pharma uses GMP (Good Manufacturing Practice) development and manufacturing standards as a reference of quality excellence with initial product registrations in Switzerland. It has worldwide rights for several unique and proprietary innovative delivery technologies, which enhance the bioavailability, and absorption of cannabinoids. The company is also progressing expansion opportunities into the North American recreational cannabis market through its wholly-owned subsidiary Mernova Medical Inc. ("Mernova Medical"), as well as the emerging psychedelics sector through target acquisition company, Halucenex Life Sciences Inc. ("Halucenex").

[jedijazz]

NEWS: Creso Pharma $COPHF and Red Light Holland Merge to Introduce The HighBrid LabTM, a Leading Global Psychedelics x Cannabis Company, Specializing in Recreational Products, Applied Science, Technology and Innovation
Red Light Holland hosted a Live Stream on www.youtube.com/redlightholland

Creso Pharma and Red Light Holland have entered into a definitive agreement to merge their businesses and create The HighBrid Lab
The HighBrid Lab is expected to have an implied pro forma equity value of $371 million (C$347 million) based on the closing price of the shares of Creso Pharma and Red Light Holland on 15 June 2021

* Mr. Bruce Linton, leading cannabis and psychedelics entrepreneur, expected to join
as Non-Executive Chairman of The HighBrid Lab’s board of directors
* Combined Company is expected to have a cash balance of approximately A$48
million, providing considerable financial flexibility to progress its growth strategy
* The Combined Global Company will trade on the Canadian Securities Exchange
(“CSE”) under the ticker symbol TRIP
* The HighBrid Lab will focus on several key growth areas:
* Expanding market and brand leadership in recreational psilocybin, supported by
education, telecounseling and technology as new markets open
* Applied science and innovation supporting long-term opportunities in
psychedelics with both naturally occurring and pharmaceutical grade drug
discovery aiming for advanced and approved product offerings through controlled
lab environments via the pending acquisitions of Halucenex and Mera Life
Sciences
* Once merged, The Highbrid Lab is able to immediately commence selling its
Animal and Human CBD products within the USA which is expected to add
considerable revenue
*Scaling recreational cannabis offering in North America by focusing on increasing market share in Canada and taking advantage of the Combined Company’s CSE listing to progress the introduction of products into the US, as well as leveraging ABN: 89 609 406 911

[budfoxfun]

Creso Pharma and Red Light Holland have entered into a definitive agreement to merge their businesses and create The HighBrid Lab.

$COPHF

[Dewayne18]

$TRIP Red Light Holland Corp shorts fall by over 50% going from 1.87 million to 858,000. News of it's merger with Creso Pharma has gotten shorts running for the hills:

https://themarketherald.ca/creso-pharma-and-red-light-holland-merge-to-introduce-the-highbrid-lab-tm-a-leading-global-psychedelics-x-cannabis-company-specializing-in-recreational-products-applied-science-technology-and-in-2021-06-16/?utm_source=stockhouse.com&utm_medium=widget&utm_campaign=stockhouse.com%7Cwebpart_news%7Cnews_tab

#PSILOCYBIN #BUY

[doinit]

good news ??? look at share price,,

[Dewayne18]

$TRIP $COPHF Red Light Holland Corp & Creso Pharma Announce Merger:

https://stockhouse.com/news/press-releases/2021/06/16/creso-pharma-and-red-light-holland-merge-to-introduce-the-highbrid-lab-tm-a

#MMJ #PSILOCYBIN

[doinit]

chart is interesting today

[doinit]

cophf,,this from ASX NEWS,,
We suspect that CPH will want to open in the US with a bang and they have probably engaged in some serious promotion over there to get their story out to the huge US investor market that loves medicinal cannabis and psychedelics investments.

[doinit]

COPHF,,,new listing,,new to u.s. market